Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature (Q35052859)

6 August 2017

1 reference

title

Frequency of extraintestinal manifestations in patients with inflammatory bowel disease in Northwest Greece and review of the literature (English)

1 reference

inflammatory bowel diseases

6 August 2017

main subject

0 references

author name string

Christodoulou DK

1

1 reference

6 August 2017

Katsanos KH

2

1 reference

6 August 2017

Kitsanou M

3

1 reference

6 August 2017

Stergiopoulou C

4

1 reference

6 August 2017

Hatzis J

5

1 reference

6 August 2017

Tsianos EV

6

1 reference

6 August 2017

publication date

1 November 2002

1 reference

Digestive and Liver Disease

6 August 2017

published in

1 reference

6 August 2017

volume

34

1 reference

6 August 2017

issue

11

1 reference

6 August 2017

page(s)

781-786

1 reference

HL-A 27 and arthropathies associated with ulcerative colitis and psoriasis.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Uveitis occurring after colectomy and ileal-rectal sleeve anastomosis for ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Ulcerative colitis and the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Pyoderma gangrenosum in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Metastatic Crohn's disease. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Interactions between chronic liver disease and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Red cell autoantibody production by colonic mononuclear cells from a patient with ulcerative colitis and autoimmune haemolytic anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Autoimmune hemolytic anemia in ulcerative colitis. A case report with review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Coombs-positive autoimmune hemolytic anemia in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Thrombotic vascular risk factors in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Thromboembolism and resistance to activated protein C in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Multiple venous thrombosis in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Nephrolithiasis as a complication of ulcerative colitis and regional enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

THE EXTRA-INTESTINAL COMPLICATIONS OF CROHNʼS DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Therapy in inflammatory bowel disease: a double-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Extraintestinal manifestations of idiopathic inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Selective resistance of mucosal T-cell activation to immunosuppression in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Improved survival with primary sclerosing cholangitis. A review of clinicopathologic features and comparison of symptomatic and asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

5-Aminosalicylates in inflammatory bowel disease: choosing the right dose

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

IL-4 hyporesponsiveness of Crohn's disease mucosal T lymphocytes: a response of polarised Th1 cells?

1 reference

https://api.crossref.org/works/10.1016%2FS1590-8658%2802%2980071-8

7 January 2021

10.1016/S1590-8658(02)80071-8

Identifiers

DOI

1 reference

6 August 2017

1 reference